Improvement programs may lead to improved Chlamydia trachomatis testing

Article

The Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT) when testing female patients under the age of 25 for Chlamydia trachomatis.

Although the Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT), many clinicians still use urine NAAT to test for Chlamydia trachomatis in sexually active female patients under the age of 25.

A new report explored whether an improvement program could be beneficial in increasing the number of clinicians using the vaginal swab NAAT. The study ultimately discovered that the quality improvement program did, in fact, lead to significant increase in the use of vaginal swabs to test for C. trachomatis.

For details on this study and its findings, visit Contemporary Pediatrics.

Recent Videos
Lauren Streicher, MD
Evaluating a miniature robotic device for hysterectomy | Image Credit: linkedin.com.
Learning what women prefer in STI preventive care
Why doxycycline PEP lacks clinical data for STI prevention in women
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
Deciding the best treatment for uterine fibroids | Image Credit: jeffersonhealth.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.